Nemucore Medical Innovations Revenue and Competitors
Estimated Revenue & Valuation
- Nemucore Medical Innovations's estimated annual revenue is currently $775k per year.
- Nemucore Medical Innovations's estimated revenue per employee is $155,000
Employee Data
- Nemucore Medical Innovations has 5 Employees.
- Nemucore Medical Innovations grew their employee count by 0% last year.
Nemucore Medical Innovations's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | SVP Operations | Reveal Email/Phone |
Nemucore Medical Innovations Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Nemucore Medical Innovations?
We envision a world where patients with cancer receive an effective drug the first time. About 30% of patients have mutations in their DNA that indicate they'll respond well to certain drugs; we develop drugs for the other 70%. We combined our drug, NMI-900, with a unique diagnostic that measures RNA rather than DNA. Our approach has the potential to select the right patient, improve survival, and limit side effects. In 5 years, we look forward to regulatory approval in AML and helping patients. Find out more at: https://wefunder.com/nemucore.medical.innovations.inc
keywords:N/A
N/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Wellesley
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 6 | -14% | N/A |
#2 | $0.9M | 6 | -14% | N/A |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.6M | 8 | -47% | N/A |
#5 | $0.6M | 8 | 0% | N/A |